Migdal Insurance & Financial Holdings Ltd. Personalis, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $6.18 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022
SELL
$7.56 - $14.3 $9,261 - $17,517
-1,225 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$12.24 - $21.25 $9,057 - $15,725
-740 Reduced 37.66%
1,225 $17,000
Q2 2021

Aug 04, 2021
SELL
$18.15 - $27.75 $391,114 - $597,984
-21,549 Reduced 91.64%
1,965 $50,000
Q1 2021

May 04, 2021
BUY
$20.71 - $51.02 $302,200 - $744,483
14,592 Added 163.55%
23,514 $579,000
Q4 2020

Feb 08, 2021
BUY
$21.84 - $44.0 $194,856 - $392,568
8,922 New
8,922 $327,000

Others Institutions Holding PSNL

# of Institutions
91
Shares Held
30.1M
Call Options Held
27.5K
Put Options Held
85.4K
View Full List

About Personalis, Inc.

PSNL Quotes by TradingView
  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email